FeesSafety
Pluang+

Lumexa Imaging reports Q3 2026 revenue growth and net income turnaround, raising EPS guidance for 2026.

Company Fundamentals
10 Nov 2026, 23:08 WIB
GlobeNewsWire
View Source
Bullish
Lumexa Imaging reports Q3 2026 revenue growth and net income turnaround, raising EPS guidance for 2026.

Lumexa Imaging announced a 5% revenue increase to $272 million and a net income of $7.2 million in Q3 2026, reversing a loss from the previous year. The company saw growth in advanced outpatient imaging volumes and opened new centers, supporting its long-term expansion plans. Lumexa raised its adjusted EPS guidance for 2026 to $0.86-$0.90, citing a lower tax rate, while maintaining revenue and EBITDA outlooks. This performance highlights Lumexa's progress in delivering cost-effective, high-quality imaging services nationwide.

Lumexa Imaging's Q3 2026 results provide context for readers. For those following the health sector, 52 of 150 US health stocks rose while 97 fell on Pluang. Notable movers include Moderna (MRNA) at USD 251.19 with a -6.62% change and a typical hold time of 58 days, Recursion Pharmaceuticals (RXRX) at USD 3.56 with a -6.44% change and 100% buy order activity, and Novavax (NVAX) at USD 10.21 with a -6.24% change and 100% sell order activity, as of Nov 11, 2026 04:02 WIB.

More News

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...

Company Fundamentals
Bullish
3 hours ago
Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...

Others
Bullish
3 hours ago
TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...

Company Fundamentals
Bullish
3 hours ago
Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...

Company Fundamentals
Neutral
5 hours ago
Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...

Market News
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App